OUTCOME AND SAFETY OF RECANALIZATION TREATMENTS IN ISCHEMIC STROKE DUE TO ACUTE BASILAR ARTERY OCCLUSION
NCT05402878 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2022-07-26
Summary
Rationale: Recently, two prospective multicenter RCT reported a potential beneficial effect of endovascular thrombectomy (EVT) in patients with an acute symptomatic basilar artery occlusion (BAO). However, the high rate of crossover in BEST study and the long-term of recruitment in BASICS study influenced the validity of the results.
Objective: To assess the outcomes and prognostic factors of recanalization therapy in patients with BAO, caused by a CTA/MRA/DSA confirmed occlusion of the basilar artery.
Study design: This is a prospective observational study. Study population: Patients with acute ischemic stroke and a confirmed basilar artery occlusion by CTA/MRA/DSA.
Main study parameters/outcomes: Favorable outcome at day 90 defined as a modified Rankin Score (mRS - functional scale) of 0-3. The estimate will be adjusted for the known prognostic variables age, time from onset to treatment, stroke severity (NIHSS), PC ASPECT and collateral flow and adjusted and unadjusted estimates with corresponding 95% confidence intervals will be reported.
Conditions
- Basilar Artery Occlusion
Sponsors & Collaborators
-
115 People's Hospital
lead OTHER_GOV
Principal Investigators
-
Huy Thang Nguyen, Professor · People 115 Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-01
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Vietnam
Study Locations
More Related Trials
-
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
NCT07203625 ·Status: RECRUITING ·Phase: PHASE4
-
Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion
NCT05701956 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment
NCT02441556 ·Status: COMPLETED ·Phase: NA
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
NCT07279259 ·Status: RECRUITING ·Phase: PHASE2
-
EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
NCT05429476 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
NCT04879615 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
NCT05415150 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308 ·Status: RECRUITING ·Phase: PHASE3
-
Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
NCT05634382 ·Status: UNKNOWN ·Phase: PHASE3
-
Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy
NCT06629116 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
NCT05105633 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
NCT01222117 ·Status: COMPLETED ·Phase: PHASE2
-
Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window
NCT01770197 ·Status: UNKNOWN
-
Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT
NCT02419781 ·Status: TERMINATED ·Phase: NA
-
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
NCT06241677 ·Status: RECRUITING ·Phase: NA
-
The Preliminary Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke
NCT07294391 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sodium Sivelestat With Mechanical Thrombectomy for Acute Stroke: A Pilot Study
NCT07196605 ·Status: COMPLETED ·Phase: NA
-
Basilar Artery Occlusion Chinese Endovascular Trial in Patients With Large Core Infarct
NCT07046299 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE
NCT04920448 ·Status: TERMINATED ·Phase: PHASE2
-
Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
NCT02016547 ·Status: TERMINATED ·Phase: PHASE4